{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T17:05:52Z","timestamp":1762103152005,"version":"build-2065373602"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T00:00:00Z","timestamp":1592870400000},"content-version":"am","delay-in-days":266,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100012615","name":"University of Texas Health Science Center at Houston","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012615","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.brainres.2019.06.017","type":"journal-article","created":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T08:47:46Z","timestamp":1560761266000},"page":"146298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Aspirin in stroke patients modifies the immunomodulatory interactions of marrow stromal cells and monocytes"],"prefix":"10.1016","volume":"1720","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8032-3755","authenticated-orcid":false,"given":"Nikunj","family":"Satani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaavya","family":"Giridhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Wewior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique D.","family":"Norris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott D.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaroslaw","family":"Aronowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean I.","family":"Savitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2019.06.017_b0005","series-title":"StatPearls","article-title":"Salicylic acid (Aspirin)","author":"Arif","year":"2019"},{"key":"10.1016\/j.brainres.2019.06.017_b0010","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/ana.410370614","article-title":"Interleukin-6 and interleukin-1 receptor antagonist in acute stroke","volume":"37","author":"Beamer","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainres.2019.06.017_b0015","doi-asserted-by":"crossref","unstructured":"CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group. Lancet. 349, 1997, 1641\u20139.","DOI":"10.1016\/S0140-6736(97)04010-5"},{"key":"10.1016\/j.brainres.2019.06.017_b0020","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1161\/01.STR.31.6.1240","article-title":"Indications for early aspirin use in acute ischemic stroke: a combined analysis of 40 000 randomized patients from the Chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups","volume":"31","author":"Chen","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.brainres.2019.06.017_b0025","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/bmj.37991.635266.44","article-title":"Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services","volume":"328","author":"Coull","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.brainres.2019.06.017_b0030","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1172\/JCI18237","article-title":"The fractalkine receptor CX3CR1 is a key mediator of atherogenesis","volume":"111","author":"Cybulsky","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.brainres.2019.06.017_b0035","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.amjmed.2005.11.013","article-title":"Aspirin to prevent heart attack and stroke: what's the right dose?","volume":"119","author":"Dalen","year":"2006","journal-title":"Am. J. Med."},{"key":"10.1016\/j.brainres.2019.06.017_b0040","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/stem.2587","article-title":"Biomechanical forces promote immune regulatory function of bone marrow mesenchymal stromal cells","volume":"35","author":"Diaz","year":"2017","journal-title":"Stem Cells"},{"key":"10.1016\/j.brainres.2019.06.017_b0045","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/0167-5699(91)90142-G","article-title":"Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro","volume":"12","author":"Dinarello","year":"1991","journal-title":"Immunol. Today"},{"key":"10.1016\/j.brainres.2019.06.017_b0050","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1161\/STROKEAHA.112.657411","article-title":"Higher plasma fractalkine is associated with better 6-month outcome from ischemic stroke","volume":"43","author":"Donohue","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.brainres.2019.06.017_b0055","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1016\/j.biochi.2013.06.020","article-title":"The stem cell secretome and its role in brain repair","volume":"95","author":"Drago","year":"2013","journal-title":"Biochimie"},{"key":"10.1016\/j.brainres.2019.06.017_b0060","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1136\/jnnp.2004.054882","article-title":"A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients","volume":"76","author":"Emsley","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.brainres.2019.06.017_b0065","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/14653249.2011.623691","article-title":"Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-gamma licensing","volume":"14","author":"Francois","year":"2012","journal-title":"Cytotherapy"},{"key":"10.1016\/j.brainres.2019.06.017_b0070","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S1474-4422(07)70274-0","article-title":"Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis","volume":"6","author":"Giles","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.brainres.2019.06.017_b0075","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1742-2094-11-74","article-title":"The temporal dynamics of plasma fractalkine levels in ischemic stroke: association with clinical severity and outcome","volume":"11","author":"Grosse","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.brainres.2019.06.017_b0080","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3109\/10520295.2011.649785","article-title":"Human adipose-derived mesenchymal stem cells: serial passaging, doubling time and cell senescence","volume":"87","author":"Gruber","year":"2012","journal-title":"Biotech. Histochem."},{"key":"10.1016\/j.brainres.2019.06.017_b0085","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S1474-4422(17)30046-7","article-title":"Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"16","author":"Hess","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.brainres.2019.06.017_b0090","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/brain\/awr063","article-title":"Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke","volume":"134","author":"Honmou","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.brainres.2019.06.017_b0095","doi-asserted-by":"crossref","unstructured":"The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group. Lancet. 349, 1997, 1569-81.","DOI":"10.1016\/S0140-6736(97)04011-7"},{"key":"10.1016\/j.brainres.2019.06.017_b0100","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1001\/archinte.159.11.1248","article-title":"A metaregression analysis of the dose-response effect of aspirin on stroke","volume":"159","author":"Johnson","year":"1999","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.brainres.2019.06.017_b0105","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Kernan","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.brainres.2019.06.017_b0110","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1002\/stem.2603","article-title":"Prostaglandin E2 indicates therapeutic efficacy of mesenchymal stem cells in experimental traumatic brain injury","volume":"35","author":"Kota","year":"2017","journal-title":"Stem Cells"},{"key":"10.1016\/j.brainres.2019.06.017_b0115","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/stem.430","article-title":"A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke","volume":"28","author":"Lee","year":"2010","journal-title":"Stem Cells"},{"key":"10.1016\/j.brainres.2019.06.017_b0120","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.rvsc.2013.12.011","article-title":"Sequential sub-passage decreases the differentiation potential of canine adipose-derived mesenchymal stem cells","volume":"96","author":"Lee","year":"2014","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.brainres.2019.06.017_b0125","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1212\/WNL.59.4.514","article-title":"Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery","volume":"59","author":"Li","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2019.06.017_b0130","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1002\/stem.1432","article-title":"Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes toward anti-inflammatory macrophages","volume":"31","author":"Melief","year":"2013","journal-title":"Stem Cells"},{"key":"10.1016\/j.brainres.2019.06.017_b0135","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/ijs.12520","article-title":"Intra-arterial bone marrow mononuclear cells (BM-MNCs) transplantation in acute ischemic stroke (IBIS trial): protocol of a phase II, randomized, dose-finding, controlled multicenter trial","volume":"10","author":"Moniche","year":"2015","journal-title":"Int. J. Stroke"},{"key":"10.1016\/j.brainres.2019.06.017_b0140","doi-asserted-by":"crossref","first-page":"8657173","DOI":"10.1155\/2016\/8657173","article-title":"Increasing dose of autologous bone marrow mononuclear cells transplantation is related to stroke outcome: results from a pooled analysis of two clinical trials","volume":"2016","author":"Moniche","year":"2016","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.brainres.2019.06.017_b0145","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1098\/rsif.2012.0271","article-title":"The sensitivity of human mesenchymal stem cells to vibration and cold storage conditions representative of cold transportation","volume":"9","author":"Nikolaev","year":"2012","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.brainres.2019.06.017_b0150","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10555-017-9675-z","article-title":"Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention","volume":"36","author":"Ornelas","year":"2017","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.brainres.2019.06.017_b0155","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jcyt.2016.10.006","article-title":"Mesenchymal stromal cell secretomes are modulated by suspension time, delivery vehicle, passage through catheter, and exposure to adjuvants","volume":"19","author":"Parsha","year":"2017","journal-title":"Cytotherapy"},{"key":"10.1016\/j.brainres.2019.06.017_b0160","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1161\/STROKEAHA.114.007028","article-title":"Intravenous autologous bone marrow mononuclear stem cell therapy for ischemic stroke: a multicentric, randomized trial","volume":"45","author":"Prasad","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.brainres.2019.06.017_b0165","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1172\/JCI119808","article-title":"The role of interleukin 1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications","volume":"100","author":"Rothwell","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.brainres.2019.06.017_b0170","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(18)31133-4","article-title":"Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials","volume":"392","author":"Rothwell","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.brainres.2019.06.017_b0175","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/s41598-017-18867-w","article-title":"Human mesenchymal stromal cell-derived extracellular vesicles modify microglial response and improve clinical outcomes in experimental spinal cord injury","volume":"8","author":"Ruppert","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.brainres.2019.06.017_b0180","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ana.22458","article-title":"Intravenous autologous bone marrow mononuclear cells for ischemic stroke","volume":"70","author":"Savitz","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainres.2019.06.017_b0185","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1634\/stemcells.20-6-530","article-title":"Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality","volume":"20","author":"Sekiya","year":"2002","journal-title":"Stem Cells"},{"key":"10.1016\/j.brainres.2019.06.017_b0190","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.cyto.2012.02.016","article-title":"Interleukin-1 receptor antagonist reverses stroke-associated peripheral immune suppression","volume":"58","author":"Smith","year":"2012","journal-title":"Cytokine"},{"key":"10.1016\/j.brainres.2019.06.017_b0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043572","article-title":"Fractalkine is expressed in early and advanced atherosclerotic lesions and supports monocyte recruitment via CX3CR1","volume":"7","author":"Stolla","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.brainres.2019.06.017_b0200","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1007\/s00018-013-1290-8","article-title":"Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration?","volume":"70","author":"Teixeira","year":"2013","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.brainres.2019.06.017_b0205","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1210\/en.2002-220964","article-title":"Interleukin-6 is an afferent signal to the hypothalamo-pituitary-adrenal axis during local inflammation in mice","volume":"144","author":"Turnbull","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.brainres.2019.06.017_b0210","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/jnr.22279","article-title":"Transplantation of human mesenchymal stem cells promotes functional improvement and increased expression of neurotrophic factors in a rat focal cerebral ischemia model","volume":"88","author":"Wakabayashi","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.brainres.2019.06.017_b0215","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.scr.2009.02.006","article-title":"Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro","volume":"3","author":"Wilkins","year":"2009","journal-title":"Stem Cell Res."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899319303440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899319303440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T17:02:43Z","timestamp":1762102963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899319303440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":43,"alternative-id":["S0006899319303440"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2019.06.017","relation":{},"ISSN":["0006-8993"],"issn-type":[{"type":"print","value":"0006-8993"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspirin in stroke patients modifies the immunomodulatory interactions of marrow stromal cells and monocytes","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2019.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"146298"}}